179 related articles for article (PubMed ID: 28971571)
1. Clinicopathological features of neuroblastic tumors with opsoclonus-myoclonus-ataxia syndrome: Follicular structure predicts a better neurological outcome.
Fukushima H; Inoue T; Takama Y; Ishii N; Okuno T; Kobayashi Y; Yoneda A; Nakamura T; Kuki I; Hara J
Pathol Int; 2017 Oct; 67(10):503-509. PubMed ID: 28971571
[TBL] [Abstract][Full Text] [Related]
2. Early Detection and Treatment of Neuroblastic Tumor with Opsoclonus-Myoclonus Syndrome Improve Neurological Outcome: A Review of Five Cases at a Single Institution in Japan.
Takama Y; Yoneda A; Nakamura T; Nakaoka T; Higashio A; Santo K; Kuki I; Kawawaki H; Tomiwa K; Hara J
Eur J Pediatr Surg; 2016 Feb; 26(1):54-9. PubMed ID: 26409265
[TBL] [Abstract][Full Text] [Related]
3. Opsoclonus-myoclonus syndrome associated with neuroblastoma: Insights into antitumor immunity.
Du H; Cai W
Pediatr Blood Cancer; 2022 Nov; 69(11):e29949. PubMed ID: 36094353
[TBL] [Abstract][Full Text] [Related]
4. Multifactorial analysis of opsoclonus-myoclonus syndrome etiology ("Tumor" vs. "No tumor") in a cohort of 356 US children.
Pranzatelli MR; Tate ED; McGee NR
Pediatr Blood Cancer; 2018 Aug; 65(8):e27097. PubMed ID: 29727049
[TBL] [Abstract][Full Text] [Related]
5. Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features-a report from the Children's Cancer Group.
Cooper R; Khakoo Y; Matthay KK; Lukens JN; Seeger RC; Stram DO; Gerbing RB; Nakagawa A; Shimada H
Med Pediatr Oncol; 2001 Jun; 36(6):623-9. PubMed ID: 11344493
[TBL] [Abstract][Full Text] [Related]
6. The Treatment of Opsoclonus-Myoclonus Syndrome Secondary to Neuroblastic Tumours-Single-Centre Experience and Literature Review.
Mizia-Malarz A; Stolpa W; Sobol-Milejska G
Medicina (Kaunas); 2020 Aug; 56(8):. PubMed ID: 32823831
[No Abstract] [Full Text] [Related]
7. [Opsoclonus-myoclonus syndrome in children with neuroblastoma: description of 3 cases].
Garus K; Balwierz W; Skowronek B; Szweda E; Kroczka S; Moryl-Bujakowska A
Przegl Lek; 2010; 67(6):427-9. PubMed ID: 21344775
[TBL] [Abstract][Full Text] [Related]
8. Neuroblastic tumors associated with opsoclonus-myoclonus syndrome: histological, immunohistochemical and molecular features of 15 Italian cases.
Gambini C; Conte M; Bernini G; Angelini P; Pession A; Paolucci P; Donfrancesco A; Veneselli E; Mazzocco K; Tonini GP; Raffaghello L; Dominici C; Morando A; Negri F; Favre A; De Bernardi B; Pistoia V
Virchows Arch; 2003 Jun; 442(6):555-62. PubMed ID: 12709798
[TBL] [Abstract][Full Text] [Related]
9. Neuroblastoma and opsoclonus-myoclonus-ataxia syndrome--clinical and pathological characteristics.
Stefanowicz J; Izycka-Swieszewska E; Drozyńska E; Pienczk J; Połczyńska K; Czauderna P; Sierota D; Bień E; Stachowicz-Stencel T; Kosiak W; Balcerska A
Folia Neuropathol; 2008; 46(3):176-85. PubMed ID: 18825593
[TBL] [Abstract][Full Text] [Related]
10. A nationwide survey of opsoclonus-myoclonus syndrome in Japanese children.
Hasegawa S; Matsushige T; Kajimoto M; Inoue H; Momonaka H; Oka M; Ohga S; Ichiyama T;
Brain Dev; 2015 Aug; 37(7):656-60. PubMed ID: 25454391
[TBL] [Abstract][Full Text] [Related]
11. Immunological mechanisms in opsoclonus-myoclonus associated neuroblastoma.
Raffaghello L; Conte M; De Grandis E; Pistoia V
Eur J Paediatr Neurol; 2009 May; 13(3):219-23. PubMed ID: 18571942
[TBL] [Abstract][Full Text] [Related]
12. Childhood opsoclonus-myoclonus syndrome: A case series from Tunisia.
Ben Achour N; Mrabet S; Rebai I; Abid I; Benrhouma H; Klaa H; Rouissi A; Kraoua I; Ben Youssef Turki I
Brain Dev; 2017 Oct; 39(9):751-755. PubMed ID: 28549713
[TBL] [Abstract][Full Text] [Related]
13. [Comprehensive treatment of neuroblastoma in children associated with opsoclonus-myoclonus-ataxia syndrome].
Zhao W; Sun Q; Xie Y; Hua Y; Xiong H; Jia J; Lu X
Zhonghua Er Ke Za Zhi; 2014 Jul; 52(7):540-3. PubMed ID: 25224062
[TBL] [Abstract][Full Text] [Related]
14. Presence of identical B-cell clone in both cerebrospinal fluid and tumor tissue in a patient with opsoclonus-myoclonus syndrome associated with neuroblastoma.
Noguchi K; Ikawa Y; Takenaka M; Sakai Y; Fujiki T; Kuroda R; Ikeda H; Nakada S; Nomura K; Sakai S; Fukuda M; Araki R; Takahashi Y; Wada T
Pediatr Hematol Oncol; 2023 May; 40(4):363-370. PubMed ID: 36125271
[TBL] [Abstract][Full Text] [Related]
15. Opsoclonus-myoclonus in children associated or not with neuroblastoma.
Krug P; Schleiermacher G; Michon J; Valteau-Couanet D; Brisse H; Peuchmaur M; Sarnacki S; Martelli H; Desguerre I; Tardieu M
Eur J Paediatr Neurol; 2010 Sep; 14(5):400-9. PubMed ID: 20110181
[TBL] [Abstract][Full Text] [Related]
16. Opsoclonus-myoclonus and anti-Hu positive limbic encephalitis in a patient with neuroblastoma.
Morales La Madrid A; Rubin CM; Kohrman M; Pytel P; Cohn SL
Pediatr Blood Cancer; 2012 Mar; 58(3):472-4. PubMed ID: 21480475
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of whole-body MRI in Opsoclonus-myoclonus syndrome: a clinical case series (3 case reports).
Storz C; Bares R; Ebinger M; Handgretinger R; Tsiflikas I; Schäfer JF
BMC Med Imaging; 2019 Aug; 19(1):70. PubMed ID: 31429709
[TBL] [Abstract][Full Text] [Related]
18. Opsoclonus-myoclonus Syndrome with Neuroblastoma in Children and their Anaesthetic Management.
Gupta A; Kundal R; Pandey M
J Coll Physicians Surg Pak; 2022 Aug; 32(8):1086-1088. PubMed ID: 35932142
[TBL] [Abstract][Full Text] [Related]
19. Serum IgG-induced microglial activation enhances neuronal cytolysis via the NO/sGC/PKG pathway in children with opsoclonus-myoclonus syndrome and neuroblastoma.
Ding X; Yang W; Ren Q; Hu J; Yang S; Han W; Wang J; Wang X; Wang H
J Neuroinflammation; 2020 Jun; 17(1):190. PubMed ID: 32546235
[TBL] [Abstract][Full Text] [Related]
20. Investigating neuroblastoma in childhood opsoclonus-myoclonus syndrome.
Brunklaus A; Pohl K; Zuberi SM; de Sousa C
Arch Dis Child; 2012 May; 97(5):461-3. PubMed ID: 21460401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
